Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Future Cardiology|October 7, 2009
Mesenchymal stromal cell and mononuclear cell therapy in heart diseaseMandana Haack-Sorensen, Tina Friis, Jens Kastrup
Cell and Tissue Banking|March 12, 2011
Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxideMichael A Cox, Jens Kastrup, Mikulas Hrubiško
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Cryopreservation and Revival of Human Mesenchymal Stromal CellsMandana Haack-Sørensen, Annette Ekblond, Jens Kastrup
Scandinavian Journal of Clinical and Laboratory Investigation|January 4, 2013
Clinical outcome after stem cell mobilization with granulocyte-colony-stimulating factor after acute ST-elevation myocardial infarction: 5-year results of the STEMMI trialRasmus S Ripa, Erik Jørgensen, Jens Kastrup
Future Cardiology|November 6, 2009
Mesenchymal stromal cells for cardiovascular repair: current status and future challengesAnders Bruun Mathiasen, Mandana Haack-Sørensen, Jens Kastrup
Ugeskrift for Laeger|February 21, 2015
[Effect of cell therapy in patients with chronic ischaemic heart disease--a survey of a Cochrane review]Anders Bruun Mathiasen, Abbas Ali Qayyum, Jens Kastrup
Current Diabetes Reports|October 27, 2014
Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complicationsAbbas Ali Qayyum, Anders Bruun Mathiasen, Jens Kastrup
European Heart Journal|June 6, 2008
Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal routeFederica Baldazzi, Erik Jørgensen, Rasmus S Ripa, et al.
Ugeskrift for Laeger|January 18, 2007
[Therapy with stem cells for acute ischemic heart disease: myocardial regeneration?]Rasmus Sejersten Ripa, Yongzhong Wang, Erik Jørgensen, et al.
European Heart Journal|October 27, 2006
Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?Jens Kastrup, Rasmus Sejersten Ripa, Yongzhong Wang, et al.
Pageof 21